Headache recurrence as a criterion for assessing efficacy of triptans: A perspective

被引：6

作者：

Aurora, SK ^{[1
]}

机构：

[1] Swedish Headache Ctr, Swedish Neurosci Inst, Seattle, WA 98116 USA

来源：

HEADACHE | 2002年 / 42卷 / 01期

关键词：

5-HT1B/1D agonist; headache recurrence; inigraine; triptan;

D O I：

10.1046/j.1526-4610.2002.02016.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：70 / 79

页数：10

共 34 条

[1] Efficacy and safety of rizatriptan wafer for the acute treatment of migraine [J].

Ahrens, SP ;

Farmer, MV ;

Williams, DL ;

Willoughby, E ;

Jiang, K ;

Block, GA ;

Visser, WH .

CEPHALALGIA, 1999, 19 (05) :525-530

[2] Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine [J].

Bomhof, M ;

Paz, J ;

Legg, N ;

Allen, C ;

Vandormael, K ;

Patel, K .

EUROPEAN NEUROLOGY, 1999, 42 (03) :173-179

[3] The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache [J].

Cull, RE ;

Price, WH ;

Dunbar, A .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (05) :490-495

[4]

DAHL FC, 1997, NEUROLOGY, V48, pA85

[5] Zolmitriptan, a 5-HT1B/1D receptor agonist for the acute oral treatment of migraine:: a multicentre, dose-range finding study [J].

Dahlof, C ;

Diener, HC ;

Goadsby, PJ ;

Massiou, H ;

Olesen, J ;

Schoenen, J ;

Wilkinson, M ;

Sweet, RM ;

Klein, KB .

EUROPEAN JOURNAL OF NEUROLOGY, 1998, 5 (06) :535-543

[6] Would any acute treatment for migraine demonstrate recurrence? [J].

Dahlof, C .

CEPHALALGIA, 1997, 17 :17-19

[7] How to assess and compare drugs in the management of migraine: success rates in terms of response and recurrence [J].

Ferrari, M .

CEPHALALGIA, 1999, 19 :2-8

[8]

FERRARI MD, 2000, HEADACHE, V40, P407

[9]

Goadsby PJ, 1999, CAN J NEUROL SCI, V26, pS20

[10]

GOADSBY PJ, 2000, 52 ANN M AM AC NEUR

← 1 2 3 4 →